⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28486930 | 1.00 | — | — | |
| SCHEMBL28486931 | 1.00 | — | — | |
| Fluoride SCHEMBL28990878 | 0.98 | GSR (0.52) | — | |
| SCHEMBL30565594 | 0.93 | GSR (0.64) | — | |
| SCHEMBL29595628 | 0.93 | GSR (0.64) | — | |
| SCHEMBL29803185 | 0.84 | — | — | |
| SCHEMBL16272838 | 0.84 | — | — | |
| SCHEMBL29581742 | 0.78 | — | — | |
| SCHEMBL57938 | 0.77 | — | — | |
| SCHEMBL57939 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220363716-A1 | METHOD FOR PRODUCING MONOVALENT CCAP PRODUCT | KAGOSHIMA UNIVERSITY (JP) | 2022-11-17 | — | — | US | claimed |
| EP-4049676-A1 | METHOD FOR PRODUCING MONOVALENT CCAP PRODUCT | Kagoshima University (JP) | 2022-08-31 | — | — | EP | claimed |
| CN-114585638-A | Method for producing 1-valent CCAP product | 国立大学法人鹿儿岛大学 | 2022-06-03 | — | — | CN | claimed |
| US-20260021213-A1 | METHOD FOR PRODUCING FC-CONTAINING MOLECULE MODIFYING REAGENT | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2026-01-22 | — | — | US | disclosed |
| EP-4682173-A1 | METHOD FOR PRODUCING RADIOLABELED ANTIBODY, RADIOLABELED ANTIBODY, AND RADIOACTIVE MEDICINE | Kagoshima University (JP) | 2026-01-21 | — | — | EP | disclosed |
| EP-4636087-A1 | ANTI-GPA33 ANTIBODY AND UTILIZATION THEREOF | Kagoshima University (JP) | 2025-10-22 | — | — | EP | disclosed |
| EP-4491628-A1 | METHOD FOR PRODUCING FC-CONTAINING MOLECULE MODIFYING REAGENT | Nihon Medi-Physics Co., Ltd. (JP) | 2025-01-15 | — | — | EP | disclosed |
| US-20240391950-A1 | PEPTIDE CROSSLINKING AGENT AND CROSSLINKED PEPTIDE WHICH IS CROSSLINKED USING SAID CROSSLINKING AGENT | KAGOSHIMA UNIVERSITY (JP) | 2024-11-28 | — | — | US | disclosed |
| WO-2024190896-A1 | METHOD FOR PRODUCING RADIOLABELED ANTIBODY, RADIOLABELED ANTIBODY, AND RADIOACTIVE MEDICINE | 国立大学法人 鹿児島大学 | 2024-09-19 | — | — | WO | disclosed |
| EP-4400509-A1 | COMPOUND, SALT OF COMPOUND, ANTIBODY MODIFICATION REAGENT, METHOD FOR PRODUCING MODIFIED ANTIBODY, AND MODIFIED ANTIBODY | Kagoshima University (JP) | 2024-07-17 | — | — | EP | disclosed |
| WO-2024111576-A1 | ANTI-GPA33 ANTIBODY AND UTILIZATION THEREOF | 国立大学法人 鹿児島大学 | 2024-05-30 | — | — | WO | disclosed |
| WO-2023171809-A1 | METHOD FOR PRODUCING FC-CONTAINING MOLECULE MODIFYING REAGENT | 日本メジフィジックス株式会社 | 2023-09-14 | — | — | WO | disclosed |
| WO-2023038082-A1 | COMPOUND, SALT OF COMPOUND, ANTIBODY MODIFICATION REAGENT, METHOD FOR PRODUCING MODIFIED ANTIBODY, AND MODIFIED ANTIBODY | 国立大学法人 鹿児島大学 | 2023-03-16 | — | — | WO | disclosed |
| EP-4049676-A1 | METHOD FOR PRODUCING MONOVALENT CCAP PRODUCT | Kagoshima University (JP) | 2022-08-31 | — | — | EP | disclosed |
| CN-114585638-A | Method for producing 1-valent CCAP product | 国立大学法人鹿儿岛大学 | 2022-06-03 | — | — | CN | disclosed |
| WO-2022097500-A1 | PEPTIDE CROSSLINKING AGENT AND CROSSLINKED PEPTIDE WHICH IS CROSSLINKED USING SAID CROSSLINKING AGENT | 国立大学法人 鹿児島大学 | 2022-05-12 | — | — | WO | disclosed |